Improving Response Inhibition in Parkinson’s Disease with Atomoxetine - Ye, Zheng; Altena, Ellemarije; Nombela, Cristina; Housden, Charlotte R.; Maxwell, Helen; Rittman, Timothy; Huddleston, Chelan; Rae, Charlotte L.; Regenthal, Ralf; Sahakian, Barbara J.; Barker, Roger A.; Robbins, Trevor W.; et al. (Biological psychiatry (1969), 2015)
Keywords: Adrenergic Uptake Inhibitors - therapeutic use; Aged; Aged, 80 and over; Archival Report; Atomoxetine; Atomoxetine Hydrochloride - therapeutic use; Brain - blood supply; Brain - drug effects; Brain - pathology; Choice Behavior - drug effects; Cognition Disorders - drug therapy; Cognition Disorders - etiology; Cognitive science; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; impulsivity; Inhibition, Psychological; Male; Middle Aged; Neural Pathways - blood supply; Neural Pathways - embryology; Neuropsychological Tests; noradrenaline; Oxygen - blood; Parkinson Disease - complications; Parkinson Disease - drug therapy; Parkinson’s disease; Psychiatric/Mental Health; Reaction Time - drug effects; response inhibition; SSRT; impulsivity; noradrenaline; Atomoxetine; SSRT; Parkinson’s disease; response inhibition; Impulsivity; Response inhibition; Noradrenaline